Cargando…
Cycloastragenol Confers Cerebral Protection after Subarachnoid Hemorrhage by Suppressing Oxidative Insults and Neuroinflammation via the SIRT1 Signaling Pathway
Subarachnoid hemorrhage (SAH) is an acute cerebral vascular disease featured by oxidative insults and neuroinflammation. Cycloastragenol (CAG), the major active component of Astragalus radix, has a wide range of biological functions. However, the potential beneficial effects and the underlying molec...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9184193/ https://www.ncbi.nlm.nih.gov/pubmed/35693703 http://dx.doi.org/10.1155/2022/3099409 |
_version_ | 1784724457599795200 |
---|---|
author | Lin, Weibin Yao, Hao Lai, Jinqing Zeng, Yile Guo, Xieli Lin, Shu Hu, Weipeng Chen, Junyan Chen, Xiangrong |
author_facet | Lin, Weibin Yao, Hao Lai, Jinqing Zeng, Yile Guo, Xieli Lin, Shu Hu, Weipeng Chen, Junyan Chen, Xiangrong |
author_sort | Lin, Weibin |
collection | PubMed |
description | Subarachnoid hemorrhage (SAH) is an acute cerebral vascular disease featured by oxidative insults and neuroinflammation. Cycloastragenol (CAG), the major active component of Astragalus radix, has a wide range of biological functions. However, the potential beneficial effects and the underlying molecular mechanisms of CAG on SAH remain obscure. In the current study, the cerebroprotective effects and mechanism of CAG on SAH were evaluated both in vivo and in vitro. Our results indicated that CAG significantly suppressed SAH-triggered oxidative insults, inflammatory mediators production, microglia activation, and the neutrophil infiltration in the brain. In addition, CAG improved neurological function and ameliorated neuronal apoptosis and degeneration after SAH. In vitro results also revealed the therapeutic effects of CAG on neurons and microglia co-culture system. Mechanistically, CAG treatment upregulated sirtuin 1 (SIRT1) expression, inhibited the levels of FoxO1, nuclear factor-kappa B, and p53 acetylation, and suppressed the subsequent oxidative, inflammatory, and apoptotic pathways. In contrast, inhibiting SIRT1 by pretreatment with Ex527 abrogated the protective actions of CAG both in vivo and in vitro models of SAH. Collectively, our findings indicated that CAG could be a promising and effective drug candidate for SAH. |
format | Online Article Text |
id | pubmed-9184193 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Hindawi |
record_format | MEDLINE/PubMed |
spelling | pubmed-91841932022-06-10 Cycloastragenol Confers Cerebral Protection after Subarachnoid Hemorrhage by Suppressing Oxidative Insults and Neuroinflammation via the SIRT1 Signaling Pathway Lin, Weibin Yao, Hao Lai, Jinqing Zeng, Yile Guo, Xieli Lin, Shu Hu, Weipeng Chen, Junyan Chen, Xiangrong Oxid Med Cell Longev Research Article Subarachnoid hemorrhage (SAH) is an acute cerebral vascular disease featured by oxidative insults and neuroinflammation. Cycloastragenol (CAG), the major active component of Astragalus radix, has a wide range of biological functions. However, the potential beneficial effects and the underlying molecular mechanisms of CAG on SAH remain obscure. In the current study, the cerebroprotective effects and mechanism of CAG on SAH were evaluated both in vivo and in vitro. Our results indicated that CAG significantly suppressed SAH-triggered oxidative insults, inflammatory mediators production, microglia activation, and the neutrophil infiltration in the brain. In addition, CAG improved neurological function and ameliorated neuronal apoptosis and degeneration after SAH. In vitro results also revealed the therapeutic effects of CAG on neurons and microglia co-culture system. Mechanistically, CAG treatment upregulated sirtuin 1 (SIRT1) expression, inhibited the levels of FoxO1, nuclear factor-kappa B, and p53 acetylation, and suppressed the subsequent oxidative, inflammatory, and apoptotic pathways. In contrast, inhibiting SIRT1 by pretreatment with Ex527 abrogated the protective actions of CAG both in vivo and in vitro models of SAH. Collectively, our findings indicated that CAG could be a promising and effective drug candidate for SAH. Hindawi 2022-06-02 /pmc/articles/PMC9184193/ /pubmed/35693703 http://dx.doi.org/10.1155/2022/3099409 Text en Copyright © 2022 Weibin Lin et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Lin, Weibin Yao, Hao Lai, Jinqing Zeng, Yile Guo, Xieli Lin, Shu Hu, Weipeng Chen, Junyan Chen, Xiangrong Cycloastragenol Confers Cerebral Protection after Subarachnoid Hemorrhage by Suppressing Oxidative Insults and Neuroinflammation via the SIRT1 Signaling Pathway |
title | Cycloastragenol Confers Cerebral Protection after Subarachnoid Hemorrhage by Suppressing Oxidative Insults and Neuroinflammation via the SIRT1 Signaling Pathway |
title_full | Cycloastragenol Confers Cerebral Protection after Subarachnoid Hemorrhage by Suppressing Oxidative Insults and Neuroinflammation via the SIRT1 Signaling Pathway |
title_fullStr | Cycloastragenol Confers Cerebral Protection after Subarachnoid Hemorrhage by Suppressing Oxidative Insults and Neuroinflammation via the SIRT1 Signaling Pathway |
title_full_unstemmed | Cycloastragenol Confers Cerebral Protection after Subarachnoid Hemorrhage by Suppressing Oxidative Insults and Neuroinflammation via the SIRT1 Signaling Pathway |
title_short | Cycloastragenol Confers Cerebral Protection after Subarachnoid Hemorrhage by Suppressing Oxidative Insults and Neuroinflammation via the SIRT1 Signaling Pathway |
title_sort | cycloastragenol confers cerebral protection after subarachnoid hemorrhage by suppressing oxidative insults and neuroinflammation via the sirt1 signaling pathway |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9184193/ https://www.ncbi.nlm.nih.gov/pubmed/35693703 http://dx.doi.org/10.1155/2022/3099409 |
work_keys_str_mv | AT linweibin cycloastragenolconferscerebralprotectionaftersubarachnoidhemorrhagebysuppressingoxidativeinsultsandneuroinflammationviathesirt1signalingpathway AT yaohao cycloastragenolconferscerebralprotectionaftersubarachnoidhemorrhagebysuppressingoxidativeinsultsandneuroinflammationviathesirt1signalingpathway AT laijinqing cycloastragenolconferscerebralprotectionaftersubarachnoidhemorrhagebysuppressingoxidativeinsultsandneuroinflammationviathesirt1signalingpathway AT zengyile cycloastragenolconferscerebralprotectionaftersubarachnoidhemorrhagebysuppressingoxidativeinsultsandneuroinflammationviathesirt1signalingpathway AT guoxieli cycloastragenolconferscerebralprotectionaftersubarachnoidhemorrhagebysuppressingoxidativeinsultsandneuroinflammationviathesirt1signalingpathway AT linshu cycloastragenolconferscerebralprotectionaftersubarachnoidhemorrhagebysuppressingoxidativeinsultsandneuroinflammationviathesirt1signalingpathway AT huweipeng cycloastragenolconferscerebralprotectionaftersubarachnoidhemorrhagebysuppressingoxidativeinsultsandneuroinflammationviathesirt1signalingpathway AT chenjunyan cycloastragenolconferscerebralprotectionaftersubarachnoidhemorrhagebysuppressingoxidativeinsultsandneuroinflammationviathesirt1signalingpathway AT chenxiangrong cycloastragenolconferscerebralprotectionaftersubarachnoidhemorrhagebysuppressingoxidativeinsultsandneuroinflammationviathesirt1signalingpathway |